Canada Life’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-8,228
| Closed | -$227K | – | 2761 |
|
|
2018
Q4 | $227K | Hold |
8,228
| – | – | ﹤0.01% | 1899 |
|
|
2018
Q3 | $230K | Hold |
8,228
| – | – | ﹤0.01% | 1945 |
|
|
2018
Q2 | $230K | Hold |
8,228
| – | – | ﹤0.01% | 1939 |
|
|
2018
Q1 | $205K | Hold |
8,228
| – | – | ﹤0.01% | 1954 |
|
|
2017
Q4 | $199K | Hold |
8,228
| – | – | ﹤0.01% | 1966 |
|
|
2017
Q3 | $226K | Hold |
8,228
| – | – | ﹤0.01% | 1911 |
|
|
2017
Q2 | $206K | Hold |
8,228
| – | – | ﹤0.01% | 1915 |
|
|
2017
Q1 | $220K | Hold |
8,228
| – | – | ﹤0.01% | 1901 |
|
|
2016
Q4 | $217K | Hold |
8,228
| – | – | ﹤0.01% | 1897 |
|
|
2016
Q3 | $205K | Hold |
8,228
| – | – | ﹤0.01% | 1902 |
|
|
2016
Q2 | $178K | Hold |
8,228
| – | – | ﹤0.01% | 1914 |
|
|
2016
Q1 | $123K | Hold |
8,228
| – | – | ﹤0.01% | 1650 |
|
|
2015
Q4 | $180K | Hold |
8,228
| – | – | ﹤0.01% | 1345 |
|
|
2015
Q3 | $130K | Hold |
8,228
| – | – | ﹤0.01% | 1516 |
|
|
2015
Q2 | $117K | Hold |
8,228
| – | – | ﹤0.01% | 1748 |
|
|
2015
Q1 | $142K | Hold |
8,228
| – | – | ﹤0.01% | 1553 |
|
|
2014
Q4 | $147K | Hold |
8,228
| – | – | ﹤0.01% | 1483 |
|
|
2014
Q3 | $108K | Buy |
8,228
+6,397
| +349% | +$86.1K | ﹤0.01% | 1628 |
|
|
2014
Q2 | $26K | Hold |
1,831
| – | – | ﹤0.01% | 2195 |
|
|
2014
Q1 | $23K | Hold |
1,831
| – | – | ﹤0.01% | 2105 |
|
|
2013
Q4 | $18K | Buy |
+1,831
| New | +$20.8K | ﹤0.01% | 2154 |
|
Other funds holding NXTM
Canada Life's NXTM Position: Q1 2019 in Review
Canada Life sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 8,228 shares — an estimated $227K sold.
Canada Life first reported a position in NXTM in Q4 2013 and held it in 21 quarters. The position peaked at $230K in Q3 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Canada Life reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Canada Life sold 8,228 NxStage Medical Inc. shares in Q1 2019, an estimated $227K.
- Canada Life first reported a position in NxStage Medical Inc. in Q4 2013 and held it in 21 quarters.
- Canada Life's NxStage Medical Inc. position peaked at $230K in Q3 2018.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Canada Life's 13F filing for Q1 2019, filed 8 May 2019.